SEC reporting owner

Alexandria Venture Investments, LLC SEC insider disclosures

Explore Alexandria Venture Investments, LLC's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-12T05:54:58.330Z

Reporting owner CIK
0001722024
Issuers
21
Coverage
verified

Inspect this reporting owner's activity

Step 1 of 3

Issuer relationships

Alexandria Venture Investments, LLC: source evidence dated 2026-10-12T05:54:58.330Z.

Issuer
Arsanis, Inc.
CIK
0001501697
Tickers
ASNS
Officer
No
Director
No
What you should see

The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.

Step 2 of 3

Which issuer and transaction does this person appear in?

Match the reviewed owner identity, issuer and transaction code. Directory eligibility does not turn every filing into a strategy signal.

What you should see

Use the linked SEC receipts and company profiles to verify what became public and when.

Step 3 of 3

Browse insider directory

Use the linked SEC receipts and company profiles to verify what became public and when.

Browse insider directory
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Issuer relationships

See the complete issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Show the table · 21 rows, 5 columns

Scroll sideways to compare all columns. Select a heading to sort.

Arsanis, Inc.0001501697ASNSNoNo
Evelo Biosciences, Inc.0001694665EVLONoNo
CONSTELLATION PHARMACEUTICALS INC0001434418CNSTNoNo
Liquidia Technologies Inc0001330436LQDANoNo
NextCure, Inc.0001661059NXTCNoNo
Applied Therapeutics, Inc.0001697532APLTNoNo
IDEAYA Biosciences, Inc.0001676725IDYANoNo
Karuna Therapeutics, Inc.0001771917KRTXNoNo
Frequency Therapeutics, Inc.0001703647FREQNoNo
IMARA Inc.0001672619IMRANoNo
Avidity Biosciences, Inc.0001599901RNANoNo
Relay Therapeutics, Inc.0001812364RLAYNoNo
Kymera Therapeutics, Inc.0001815442KYMRNoNo
Metacrine, Inc.0001634379MTCRNoNo
Silverback Therapeutics, Inc.0001671858SBTXNoNo
Vor Biopharma Inc.0001817229VORNoNo
Singular Genomics Systems, Inc.0001850906OMICNoNo
Xilio Therapeutics, Inc.0001840233XLONoNo
Vigil Neuroscience, Inc.0001827087VIGLNoNo
GreenLight Biosciences Holdings, PBC0001822691GRNANoNo
TRex Bio, Inc.0002139097TRXBNoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Show the table · 0 rows, 6 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.